Native human adipose stromal cells: localization, morphology and phenotype.
OBJECTIVE
Beside having roles in energy homeostasis and endocrine modulation, adipose tissue (AT) is now considered a promising source of mesenchymal stromal cells (adipose-derived stromal cells or ASCs) for regenerative medicine. Despite numerous studies on cultured ASCs, native human ASCs are rarely investigated. Indeed, the phenotype of ASCs in their native state, their localization within AT and comparison with bone marrow-derived mesenchymal stromal cells (BM-MSCs) has been poorly investigated.


METHODS
To address these issues, the stroma vascular fraction (SVF) of human AT was extracted and native cell subtypes were isolated by immunoselection to study their clonogenic potential in culture. Immunohistology on samples of human AT in combination with reconstruction of confocal sections were performed in order to localize ASCs.


RESULTS
Compared with BM-MNCs, all native ASCs were found in the CD34(+) cell fraction of the AT-SVF. Native ASCs expressed classical mesenchymal markers described for BM-MSCs. Interestingly, CD34 expression decreased during ASC cell culture and was negatively correlated with cell proliferation rate. Immunohistological analysis revealed that native ASCs exhibited specific morphological features with protrusions. They were found scattered in AT stroma and did not express in vivo pericytic markers such as NG2, CD140b or alpha-smooth muscle actin, which appeared during the culture process. Finally, ASCs spontaneous commitment to adipocytic lineage was enhanced in AT from obese humans.


CONCLUSIONS
The use of complementary methodological approaches to study native human ASCs revealed their immunophenotype, their specific morphology, their location within AT and their stemness. Furthermore, our data strongly suggest that human ASCs participate in adipogenesis during AT development.
Institut National de Santé et de Recherche Médicale (INSERM), U858, Université Toulouse III Paul Sabatier, Institut de Médecine Moléculaire de Rangueil (I2MR), Equipe n°1 AVENIR, Toulouse, France.
M
M
Maumus
J-A
JA
Peyrafitte
R
R
D'Angelo
C
C
Fournier-Wirth
A
A
Bouloumié
L
L
Casteilla
C
C
Sengenès
P
P
Bourin
D050156:Adipogenesis / Q000235:genetics; D000273:Adipose Tissue / Q000166:cytology*; D000328:Adult; D015415:Biomarkers; D002454:Cell Differentiation / Q000235:genetics / Q000502:physiology*; D002478:Cells, Cultured; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D016130:Immunophenotyping; D059630:Mesenchymal Stem Cells / Q000166:cytology; D009765:Obesity / Q000235:genetics; D010641:Phenotype; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017154:Stromal Cells / Q000166:cytology
D015415:Biomarkers
Cell Prolif. 2008 Oct;41(5):803-12
18616697
J Exp Med. 2005 May 2;201(9):1397-405
15867092
Cells Tissues Organs. 2003;174(3):101-9
12835573
Stem Cells. 2006 Nov;24(11):2582-91
16873762
J Cell Sci. 2004 Aug 15;117(Pt 18):4289-99
15292397
Cell. 2008 Oct 17;135(2):240-9
18835024
Poult Sci. 1997 Jan;76(1):118-23
9037698
Science. 2007 Dec 21;318(5858):1917-20
18029452
Stem Cells. 2006 May;24(5):1294-301
16410387
Cell Stem Cell. 2007 Oct 11;1(4):364-6
18371374
J Clin Endocrinol Metab. 2008 Oct;93(10):4098-106
18682517
Endocrinol Metab Clin North Am. 2008 Sep;37(3):753-68, x-xi
18775362
J Cell Sci. 2004 Jun 15;117(Pt 14):2971-81
15173316
Acta Med Scand. 1971 Nov;190(5):363-7
5149263
Invest Ophthalmol Vis Sci. 2004 Sep;45(9):2985-91
15326111
Tissue Eng Part C Methods. 2008 Sep;14(3):233-42
18781836
Circulation. 2004 Feb 10;109(5):656-63
14734516
Science. 1997 Feb 14;275(5302):964-7
9020076
Cell. 2006 Aug 25;126(4):663-76
16904174
Science. 2005 Sep 23;309(5743):2064-7
16141372
J Cell Sci. 2008 Nov 15;121(Pt 22):3683-92
18987355
Nature. 2002 Jul 4;418(6893):41-9
12077603
Histol Histopathol. 2010 Jun;25(6):807-15
20376787
Int J Obes Relat Metab Disord. 2003 Aug;27(8):889-95
12861228
J Cell Physiol. 2006 Jul;208(1):64-76
16557516
Blood. 1990 Jun 15;75(12):2417-26
1693532
Mol Biol Cell. 2005 Mar;16(3):1131-41
15635089
Annu Rev Pharmacol Toxicol. 2005;45:119-46
15822173
Cytotherapy. 2007;9(5):439-50
17786605
Blood. 2008 Nov 1;112(9):3543-53
18948588
Cell Cycle. 2008 Mar 15;7(6):725-8
18239456
Circulation. 2004 Jul 20;110(3):349-55
15238461
Circ Res. 2007 May 11;100(9):1249-60
17495232
Stem Cells. 2006 Feb;24(2):376-85
16322640
Leukemia. 2006 May;20(5):857-69
16498386
J Dermatol Sci. 2007 Oct;48(1):43-52
17644316
J Cell Physiol. 2008 Jul;216(1):3-13
18264975
Cytotherapy. 2006;8(4):315-7
16923606
Circulation. 2004 Mar 16;109(10):1292-8
14993122
Mol Biol Cell. 2002 Dec;13(12):4279-95
12475952
Br J Haematol. 2005 Apr;129(1):118-29
15801964
Cell Stem Cell. 2008 Sep 11;3(3):301-13
18786417
Clin Endocrinol Metab. 1976 Jul;5(2):299-311
1085232
Blood. 1991 Dec 1;78(11):2848-53
1720038
Blood. 1994 Oct 15;84(8):2554-65
7522633
Diabetes. 2010 Jan;59(1):105-9
19846802
Exp Hematol. 2005 Nov;33(11):1402-16
16263424
Blood. 1995 Jan 1;85(1):96-105
7528578
Mol Hum Reprod. 2001 Dec;7(12):1151-7
11719592
Curr Stem Cell Res Ther. 2007 Sep;2(3):221-7
18220905
Circ Res. 2008 Jan 4;102(1):77-85
17967785
Nature. 2008 Jun 5;453(7196):783-7
18454136
PLoS Comput Biol. 2009 Mar;5(3):e1000324
19325873
Stem Cells. 2008 Jan;26(1):202-11
17916802
Stem Cells Dev. 2008 Dec;17(6):1053-63
18597617
Cell Physiol Biochem. 2004;14(4-6):261-8
15319529
Stem Cells. 2007 Sep;25(9):2269-76
17525234
J Cell Physiol. 2005 Oct;205(1):114-22
15880450
Stem Cells. 1997;15(5):368-77
9323800
Obes Rev. 2001 Nov;2(4):239-54
12119995